← Back to headlines
GRAIL receives new ratings from Mizuho and Piper following study setback
Biotechnology company GRAIL has been rated 'new Neural' by Mizuho and Piper, following a recent setback in its studies.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
